SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'MC5'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FM6_D_BRLD503_1 (PEROXISOMEPROLIFERATORACTIVATED RECEPTORGAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 12 / 12 | GLY A 284CYH A 285SER A 289HIS A 323TYR A 327MET A 348LEU A 353MET A 364HIS A 449LEU A 453LEU A 469TYR A 473 | MC5 A 1 ( 4.5A)MC5 A 1 (-3.6A)MC5 A 1 (-2.6A)MC5 A 1 (-3.8A)NoneMC5 A 1 ( 4.0A)MC5 A 1 (-4.7A)MC5 A 1 (-3.7A)MC5 A 1 (-3.9A)MC5 A 1 (-4.2A)MC5 A 1 (-4.1A)MC5 A 1 (-4.9A) | 0.48A | 1fm6D-3b0qA:39.8 | 1fm6D-3b0qA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FM6_D_BRLD503_1 (PEROXISOMEPROLIFERATORACTIVATED RECEPTORGAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 6 / 12 | GLY A 284LEU A 356HIS A 449LEU A 453LEU A 469TYR A 473 | MC5 A 1 ( 4.5A)NoneMC5 A 1 (-3.9A)MC5 A 1 (-4.2A)MC5 A 1 (-4.1A)MC5 A 1 (-4.9A) | 1.37A | 1fm6D-3b0qA:39.8 | 1fm6D-3b0qA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FM6_D_BRLD503_2 (PEROXISOMEPROLIFERATORACTIVATED RECEPTORGAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 4 / 4 | ILE A 281LEU A 330VAL A 339ILE A 341 | MC5 A 1 ( 4.8A)MC5 A 1 (-4.4A)MC5 A 1 (-4.6A)MC5 A 1 (-4.5A) | 0.21A | 1fm6D-3b0qA:39.8 | 1fm6D-3b0qA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FM6_X_BRLX504_1 (PEROXISOMEPROLIFERATORACTIVATED RECEPTORGAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 5 / 12 | ILE A 281PHE A 282GLY A 284CYH A 285LEU A 452 | MC5 A 1 ( 4.8A)MC5 A 1 (-4.4A)MC5 A 1 ( 4.5A)MC5 A 1 (-3.6A)None | 1.36A | 1fm6X-3b0qA:39.4 | 1fm6X-3b0qA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FM6_X_BRLX504_1 (PEROXISOMEPROLIFERATORACTIVATED RECEPTORGAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 12 / 12 | ILE A 281PHE A 282GLY A 284CYH A 285SER A 289HIS A 323TYR A 327MET A 364HIS A 449LEU A 453LEU A 469TYR A 473 | MC5 A 1 ( 4.8A)MC5 A 1 (-4.4A)MC5 A 1 ( 4.5A)MC5 A 1 (-3.6A)MC5 A 1 (-2.6A)MC5 A 1 (-3.8A)NoneMC5 A 1 (-3.7A)MC5 A 1 (-3.9A)MC5 A 1 (-4.2A)MC5 A 1 (-4.1A)MC5 A 1 (-4.9A) | 0.68A | 1fm6X-3b0qA:39.4 | 1fm6X-3b0qA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ZGY_A_BRLA503_1 (PEROXISOMEPROLIFERATORACTIVATED RECEPTORGAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 12 / 12 | PHE A 282GLY A 284CYH A 285SER A 289HIS A 323TYR A 327LEU A 330LEU A 353MET A 364HIS A 449LEU A 469TYR A 473 | MC5 A 1 (-4.4A)MC5 A 1 ( 4.5A)MC5 A 1 (-3.6A)MC5 A 1 (-2.6A)MC5 A 1 (-3.8A)NoneMC5 A 1 (-4.4A)MC5 A 1 (-4.7A)MC5 A 1 (-3.7A)MC5 A 1 (-3.9A)MC5 A 1 (-4.1A)MC5 A 1 (-4.9A) | 0.39A | 1zgyA-3b0qA:40.1 | 1zgyA-3b0qA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ZGY_A_BRLA503_1 (PEROXISOMEPROLIFERATORACTIVATED RECEPTORGAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 6 / 12 | PHE A 282GLY A 284LEU A 356HIS A 449LEU A 469TYR A 473 | MC5 A 1 (-4.4A)MC5 A 1 ( 4.5A)NoneMC5 A 1 (-3.9A)MC5 A 1 (-4.1A)MC5 A 1 (-4.9A) | 1.44A | 1zgyA-3b0qA:40.1 | 1zgyA-3b0qA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ZGY_A_BRLA503_2 (PEROXISOMEPROLIFERATORACTIVATED RECEPTORGAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 5 / 5 | ILE A 281ILE A 326ILE A 341MET A 348LEU A 453 | MC5 A 1 ( 4.8A)MC5 A 1 ( 4.9A)MC5 A 1 (-4.5A)MC5 A 1 ( 4.0A)MC5 A 1 (-4.2A) | 0.37A | 1zgyA-3b0qA:40.1 | 1zgyA-3b0qA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2PRG_A_BRLA1_1 (PEROXISOMEPROLIFERATORACTIVATED RECEPTORGAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 11 / 12 | GLY A 284CYH A 285GLN A 286SER A 289HIS A 323TYR A 327LEU A 330MET A 348MET A 364HIS A 449TYR A 473 | MC5 A 1 ( 4.5A)MC5 A 1 (-3.6A)NoneMC5 A 1 (-2.6A)MC5 A 1 (-3.8A)NoneMC5 A 1 (-4.4A)MC5 A 1 ( 4.0A)MC5 A 1 (-3.7A)MC5 A 1 (-3.9A)MC5 A 1 (-4.9A) | 0.56A | 2prgA-3b0qA:40.0 | 2prgA-3b0qA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2PRG_A_BRLA1_1 (PEROXISOMEPROLIFERATORACTIVATED RECEPTORGAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 11 / 12 | PHE A 282GLY A 284CYH A 285SER A 289HIS A 323TYR A 327LEU A 330MET A 348MET A 364HIS A 449TYR A 473 | MC5 A 1 (-4.4A)MC5 A 1 ( 4.5A)MC5 A 1 (-3.6A)MC5 A 1 (-2.6A)MC5 A 1 (-3.8A)NoneMC5 A 1 (-4.4A)MC5 A 1 ( 4.0A)MC5 A 1 (-3.7A)MC5 A 1 (-3.9A)MC5 A 1 (-4.9A) | 0.55A | 2prgA-3b0qA:40.0 | 2prgA-3b0qA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2PRG_A_BRLA1_2 (PEROXISOMEPROLIFERATORACTIVATED RECEPTORGAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 3 / 3 | ILE A 281ILE A 341LEU A 453 | MC5 A 1 ( 4.8A)MC5 A 1 (-4.5A)MC5 A 1 (-4.2A) | 0.48A | 2prgA-3b0qA:40.0 | 2prgA-3b0qA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2PRG_B_BRLB2_1 (PEROXISOMEPROLIFERATORACTIVATED RECEPTORGAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 12 / 12 | PHE A 282CYH A 285SER A 289HIS A 323TYR A 327LEU A 330VAL A 339MET A 364HIS A 449LEU A 453LEU A 469TYR A 473 | MC5 A 1 (-4.4A)MC5 A 1 (-3.6A)MC5 A 1 (-2.6A)MC5 A 1 (-3.8A)NoneMC5 A 1 (-4.4A)MC5 A 1 (-4.6A)MC5 A 1 (-3.7A)MC5 A 1 (-3.9A)MC5 A 1 (-4.2A)MC5 A 1 (-4.1A)MC5 A 1 (-4.9A) | 0.45A | 2prgB-3b0qA:38.8 | 2prgB-3b0qA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2XKW_A_P1BA1478_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 11 / 12 | PHE A 282CYH A 285HIS A 323TYR A 327LEU A 330ILE A 341MET A 348MET A 364HIS A 449LEU A 469TYR A 473 | MC5 A 1 (-4.4A)MC5 A 1 (-3.6A)MC5 A 1 (-3.8A)NoneMC5 A 1 (-4.4A)MC5 A 1 (-4.5A)MC5 A 1 ( 4.0A)MC5 A 1 (-3.7A)MC5 A 1 (-3.9A)MC5 A 1 (-4.1A)MC5 A 1 (-4.9A) | 0.48A | 2xkwA-3b0qA:42.6 | 2xkwA-3b0qA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2XKW_A_P1BA1478_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 11 / 12 | PHE A 282SER A 289HIS A 323TYR A 327LEU A 330ILE A 341MET A 348MET A 364HIS A 449LEU A 469TYR A 473 | MC5 A 1 (-4.4A)MC5 A 1 (-2.6A)MC5 A 1 (-3.8A)NoneMC5 A 1 (-4.4A)MC5 A 1 (-4.5A)MC5 A 1 ( 4.0A)MC5 A 1 (-3.7A)MC5 A 1 (-3.9A)MC5 A 1 (-4.1A)MC5 A 1 (-4.9A) | 0.47A | 2xkwA-3b0qA:42.6 | 2xkwA-3b0qA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2XKW_A_P1BA1478_2 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 7 / 7 | LEU A 255GLU A 259ILE A 281GLN A 286ARG A 288ALA A 292ILE A 326 | NoneNoneMC5 A 1 ( 4.8A)NoneNoneNoneMC5 A 1 ( 4.9A) | 0.24A | 2xkwA-3b0qA:42.6 | 2xkwA-3b0qA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2XKW_B_P1BB1475_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 7 / 12 | ILE A 249ARG A 288SER A 289ALA A 292LEU A 330MET A 348MET A 364 | NoneNoneMC5 A 1 (-2.6A)NoneMC5 A 1 (-4.4A)MC5 A 1 ( 4.0A)MC5 A 1 (-3.7A) | 0.54A | 2xkwB-3b0qA:37.2 | 2xkwB-3b0qA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2XKW_B_P1BB1475_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 8 / 12 | ILE A 249GLU A 259ARG A 288ALA A 292LEU A 330ILE A 341MET A 348MET A 364 | NoneNoneNoneNoneMC5 A 1 (-4.4A)MC5 A 1 (-4.5A)MC5 A 1 ( 4.0A)MC5 A 1 (-3.7A) | 0.57A | 2xkwB-3b0qA:37.2 | 2xkwB-3b0qA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2XKW_B_P1BB1475_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 8 / 12 | ILE A 249GLU A 259CYH A 285ARG A 288ALA A 292LEU A 330ILE A 341MET A 364 | NoneNoneMC5 A 1 (-3.6A)NoneNoneMC5 A 1 (-4.4A)MC5 A 1 (-4.5A)MC5 A 1 (-3.7A) | 0.78A | 2xkwB-3b0qA:37.2 | 2xkwB-3b0qA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2XKW_B_P1BB1475_2 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 5 / 6 | LEU A 255ARG A 280ILE A 281ILE A 326MET A 329 | NoneNoneMC5 A 1 ( 4.8A)MC5 A 1 ( 4.9A)None | 0.65A | 2xkwB-3b0qA:37.2 | 2xkwB-3b0qA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2XKW_B_P1BB1475_2 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 5 / 6 | LEU A 255ILE A 281ILE A 326MET A 329LEU A 333 | NoneMC5 A 1 ( 4.8A)MC5 A 1 ( 4.9A)NoneNone | 0.28A | 2xkwB-3b0qA:37.2 | 2xkwB-3b0qA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ADS_A_IMNA1_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 8 / 10 | GLU A 259ARG A 280ILE A 281GLY A 284LEU A 330ILE A 341MET A 348MET A 364 | NoneNoneMC5 A 1 ( 4.8A)MC5 A 1 ( 4.5A)MC5 A 1 (-4.4A)MC5 A 1 (-4.5A)MC5 A 1 ( 4.0A)MC5 A 1 (-3.7A) | 0.72A | 3adsA-3b0qA:42.0 | 3adsA-3b0qA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ADS_A_IMNA1_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 8 / 10 | GLU A 259ILE A 281GLY A 284ARG A 288LEU A 330ILE A 341MET A 348MET A 364 | NoneMC5 A 1 ( 4.8A)MC5 A 1 ( 4.5A)NoneMC5 A 1 (-4.4A)MC5 A 1 (-4.5A)MC5 A 1 ( 4.0A)MC5 A 1 (-3.7A) | 0.52A | 3adsA-3b0qA:42.0 | 3adsA-3b0qA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ADS_A_IMNA1_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 8 / 10 | GLU A 259ILE A 281GLY A 284CYH A 285ARG A 288LEU A 330ILE A 341MET A 364 | NoneMC5 A 1 ( 4.8A)MC5 A 1 ( 4.5A)MC5 A 1 (-3.6A)NoneMC5 A 1 (-4.4A)MC5 A 1 (-4.5A)MC5 A 1 (-3.7A) | 0.65A | 3adsA-3b0qA:42.0 | 3adsA-3b0qA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ADS_A_IMNA2_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 9 / 12 | CYH A 285HIS A 323LEU A 330LEU A 353LYS A 367HIS A 449LEU A 453LEU A 469TYR A 473 | MC5 A 1 (-3.6A)MC5 A 1 (-3.8A)MC5 A 1 (-4.4A)MC5 A 1 (-4.7A)NoneMC5 A 1 (-3.9A)MC5 A 1 (-4.2A)MC5 A 1 (-4.1A)MC5 A 1 (-4.9A) | 0.62A | 3adsA-3b0qA:42.0 | 3adsA-3b0qA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ADS_A_IMNA2_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 6 / 12 | CYH A 285LEU A 356HIS A 449LEU A 453LEU A 469TYR A 473 | MC5 A 1 (-3.6A)NoneMC5 A 1 (-3.9A)MC5 A 1 (-4.2A)MC5 A 1 (-4.1A)MC5 A 1 (-4.9A) | 1.32A | 3adsA-3b0qA:42.0 | 3adsA-3b0qA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ADS_A_IMNA2_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 5 / 12 | PHE A 282CYH A 285HIS A 323LEU A 469TYR A 473 | MC5 A 1 (-4.4A)MC5 A 1 (-3.6A)MC5 A 1 (-3.8A)MC5 A 1 (-4.1A)MC5 A 1 (-4.9A) | 1.13A | 3adsA-3b0qA:42.0 | 3adsA-3b0qA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ADS_A_IMNA2_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 5 / 12 | PHE A 282SER A 289HIS A 323LEU A 469TYR A 473 | MC5 A 1 (-4.4A)MC5 A 1 (-2.6A)MC5 A 1 (-3.8A)MC5 A 1 (-4.1A)MC5 A 1 (-4.9A) | 0.87A | 3adsA-3b0qA:42.0 | 3adsA-3b0qA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ADS_A_IMNA2_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 9 / 12 | SER A 289HIS A 323LEU A 330LEU A 353LYS A 367HIS A 449LEU A 453LEU A 469TYR A 473 | MC5 A 1 (-2.6A)MC5 A 1 (-3.8A)MC5 A 1 (-4.4A)MC5 A 1 (-4.7A)NoneMC5 A 1 (-3.9A)MC5 A 1 (-4.2A)MC5 A 1 (-4.1A)MC5 A 1 (-4.9A) | 0.59A | 3adsA-3b0qA:42.0 | 3adsA-3b0qA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ADS_A_IMNA2_2 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 6 / 6 | ILE A 281ILE A 326TYR A 327LEU A 356PHE A 360MET A 364 | MC5 A 1 ( 4.8A)MC5 A 1 ( 4.9A)NoneNoneNoneMC5 A 1 (-3.7A) | 0.37A | 3adsA-3b0qA:42.0 | 3adsA-3b0qA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ADS_B_IMNB3_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 8 / 12 | GLY A 284ARG A 288SER A 289ALA A 292ILE A 326LEU A 330LEU A 333VAL A 339 | MC5 A 1 ( 4.5A)NoneMC5 A 1 (-2.6A)NoneMC5 A 1 ( 4.9A)MC5 A 1 (-4.4A)NoneMC5 A 1 (-4.6A) | 0.59A | 3adsB-3b0qA:36.8 | 3adsB-3b0qA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ADS_B_IMNB3_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 7 / 12 | GLY A 284CYH A 285ARG A 288LEU A 330LEU A 333VAL A 339MET A 364 | MC5 A 1 ( 4.5A)MC5 A 1 (-3.6A)NoneMC5 A 1 (-4.4A)NoneMC5 A 1 (-4.6A)MC5 A 1 (-3.7A) | 0.77A | 3adsB-3b0qA:36.8 | 3adsB-3b0qA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ADS_B_IMNB3_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 10 / 12 | ILE A 281GLY A 284ARG A 288ALA A 292ILE A 326LEU A 330LEU A 333VAL A 339ILE A 341MET A 364 | MC5 A 1 ( 4.8A)MC5 A 1 ( 4.5A)NoneNoneMC5 A 1 ( 4.9A)MC5 A 1 (-4.4A)NoneMC5 A 1 (-4.6A)MC5 A 1 (-4.5A)MC5 A 1 (-3.7A) | 0.44A | 3adsB-3b0qA:36.8 | 3adsB-3b0qA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ADX_A_IMNA2_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 9 / 12 | CYH A 285GLN A 286HIS A 323TYR A 327LEU A 330LEU A 353HIS A 449LEU A 469TYR A 473 | MC5 A 1 (-3.6A)NoneMC5 A 1 (-3.8A)NoneMC5 A 1 (-4.4A)MC5 A 1 (-4.7A)MC5 A 1 (-3.9A)MC5 A 1 (-4.1A)MC5 A 1 (-4.9A) | 0.66A | 3adxA-3b0qA:41.4 | 3adxA-3b0qA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ADX_A_IMNA2_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 6 / 12 | CYH A 285GLN A 286LEU A 356HIS A 449LEU A 469TYR A 473 | MC5 A 1 (-3.6A)NoneNoneMC5 A 1 (-3.9A)MC5 A 1 (-4.1A)MC5 A 1 (-4.9A) | 1.39A | 3adxA-3b0qA:41.4 | 3adxA-3b0qA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ADX_A_IMNA2_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 9 / 12 | GLN A 286SER A 289HIS A 323TYR A 327LEU A 330LEU A 353HIS A 449LEU A 469TYR A 473 | NoneMC5 A 1 (-2.6A)MC5 A 1 (-3.8A)NoneMC5 A 1 (-4.4A)MC5 A 1 (-4.7A)MC5 A 1 (-3.9A)MC5 A 1 (-4.1A)MC5 A 1 (-4.9A) | 0.69A | 3adxA-3b0qA:41.4 | 3adxA-3b0qA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ADX_A_IMNA2_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 6 / 12 | PHE A 282CYH A 285GLN A 286HIS A 323LEU A 469TYR A 473 | MC5 A 1 (-4.4A)MC5 A 1 (-3.6A)NoneMC5 A 1 (-3.8A)MC5 A 1 (-4.1A)MC5 A 1 (-4.9A) | 1.07A | 3adxA-3b0qA:41.4 | 3adxA-3b0qA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ADX_A_IMNA2_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 6 / 12 | PHE A 282GLN A 286SER A 289HIS A 323LEU A 469TYR A 473 | MC5 A 1 (-4.4A)NoneMC5 A 1 (-2.6A)MC5 A 1 (-3.8A)MC5 A 1 (-4.1A)MC5 A 1 (-4.9A) | 0.89A | 3adxA-3b0qA:41.4 | 3adxA-3b0qA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ADX_A_IMNA2_2 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 6 / 7 | ILE A 281ILE A 326LEU A 356MET A 364LYS A 367LEU A 453 | MC5 A 1 ( 4.8A)MC5 A 1 ( 4.9A)NoneMC5 A 1 (-3.7A)NoneMC5 A 1 (-4.2A) | 0.52A | 3adxA-3b0qA:41.4 | 3adxA-3b0qA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ADX_A_IMNA2_2 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 6 / 7 | ILE A 281ILE A 326LEU A 356PHE A 360MET A 364LYS A 367 | MC5 A 1 ( 4.8A)MC5 A 1 ( 4.9A)NoneNoneMC5 A 1 (-3.7A)None | 0.33A | 3adxA-3b0qA:41.4 | 3adxA-3b0qA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ADX_B_IMNB3_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 11 / 12 | LEU A 228GLY A 284ARG A 288SER A 289ALA A 292ILE A 326LEU A 330LEU A 333VAL A 339ILE A 341MET A 364 | NoneMC5 A 1 ( 4.5A)NoneMC5 A 1 (-2.6A)NoneMC5 A 1 ( 4.9A)MC5 A 1 (-4.4A)NoneMC5 A 1 (-4.6A)MC5 A 1 (-4.5A)MC5 A 1 (-3.7A) | 0.57A | 3adxB-3b0qA:36.8 | 3adxB-3b0qA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ADX_B_IMNB3_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 9 / 12 | LEU A 228GLY A 284CYH A 285ARG A 288ALA A 292LEU A 330LEU A 333VAL A 339MET A 364 | NoneMC5 A 1 ( 4.5A)MC5 A 1 (-3.6A)NoneNoneMC5 A 1 (-4.4A)NoneMC5 A 1 (-4.6A)MC5 A 1 (-3.7A) | 0.80A | 3adxB-3b0qA:36.8 | 3adxB-3b0qA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CS8_A_BRLA503_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 5 / 12 | CYH A 285HIS A 323ILE A 326LEU A 330MET A 364 | MC5 A 1 (-3.6A)MC5 A 1 (-3.8A)MC5 A 1 ( 4.9A)MC5 A 1 (-4.4A)MC5 A 1 (-3.7A) | 0.85A | 3cs8A-3b0qA:38.9 | 3cs8A-3b0qA:98.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CS8_A_BRLA503_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 5 / 12 | CYH A 285HIS A 323LEU A 330MET A 364LYS A 367 | MC5 A 1 (-3.6A)MC5 A 1 (-3.8A)MC5 A 1 (-4.4A)MC5 A 1 (-3.7A)None | 0.96A | 3cs8A-3b0qA:38.9 | 3cs8A-3b0qA:98.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CS8_A_BRLA503_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 6 / 12 | GLY A 284CYH A 285SER A 289ILE A 326LEU A 330MET A 364 | MC5 A 1 ( 4.5A)MC5 A 1 (-3.6A)MC5 A 1 (-2.6A)MC5 A 1 ( 4.9A)MC5 A 1 (-4.4A)MC5 A 1 (-3.7A) | 0.92A | 3cs8A-3b0qA:38.9 | 3cs8A-3b0qA:98.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CS8_A_BRLA503_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 7 / 12 | GLY A 284CYH A 285SER A 289LEU A 330MET A 364LYS A 367HIS A 449 | MC5 A 1 ( 4.5A)MC5 A 1 (-3.6A)MC5 A 1 (-2.6A)MC5 A 1 (-4.4A)MC5 A 1 (-3.7A)NoneMC5 A 1 (-3.9A) | 1.15A | 3cs8A-3b0qA:38.9 | 3cs8A-3b0qA:98.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CS8_A_BRLA503_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 6 / 12 | GLY A 284MET A 364LYS A 367HIS A 449LEU A 453TYR A 473 | MC5 A 1 ( 4.5A)MC5 A 1 (-3.7A)NoneMC5 A 1 (-3.9A)MC5 A 1 (-4.2A)MC5 A 1 (-4.9A) | 1.25A | 3cs8A-3b0qA:38.9 | 3cs8A-3b0qA:98.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CS8_A_BRLA503_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 7 / 12 | GLY A 284SER A 289ILE A 326LEU A 330MET A 364LEU A 469TYR A 473 | MC5 A 1 ( 4.5A)MC5 A 1 (-2.6A)MC5 A 1 ( 4.9A)MC5 A 1 (-4.4A)MC5 A 1 (-3.7A)MC5 A 1 (-4.1A)MC5 A 1 (-4.9A) | 0.64A | 3cs8A-3b0qA:38.9 | 3cs8A-3b0qA:98.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CS8_A_BRLA503_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 8 / 12 | GLY A 284SER A 289LEU A 330MET A 364LYS A 367HIS A 449LEU A 469TYR A 473 | MC5 A 1 ( 4.5A)MC5 A 1 (-2.6A)MC5 A 1 (-4.4A)MC5 A 1 (-3.7A)NoneMC5 A 1 (-3.9A)MC5 A 1 (-4.1A)MC5 A 1 (-4.9A) | 1.09A | 3cs8A-3b0qA:38.9 | 3cs8A-3b0qA:98.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CS8_A_BRLA503_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 5 / 12 | HIS A 323ILE A 326LEU A 330MET A 364TYR A 473 | MC5 A 1 (-3.8A)MC5 A 1 ( 4.9A)MC5 A 1 (-4.4A)MC5 A 1 (-3.7A)MC5 A 1 (-4.9A) | 0.74A | 3cs8A-3b0qA:38.9 | 3cs8A-3b0qA:98.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CS8_A_BRLA503_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 5 / 12 | HIS A 323LEU A 330MET A 364LYS A 367TYR A 473 | MC5 A 1 (-3.8A)MC5 A 1 (-4.4A)MC5 A 1 (-3.7A)NoneMC5 A 1 (-4.9A) | 0.82A | 3cs8A-3b0qA:38.9 | 3cs8A-3b0qA:98.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CS8_A_BRLA503_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 5 / 12 | HIS A 323MET A 364LYS A 367LEU A 453TYR A 473 | MC5 A 1 (-3.8A)MC5 A 1 (-3.7A)NoneMC5 A 1 (-4.2A)MC5 A 1 (-4.9A) | 1.01A | 3cs8A-3b0qA:38.9 | 3cs8A-3b0qA:98.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3DZY_D_BRLD478_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 7 / 12 | PHE A 282ARG A 288SER A 289HIS A 323TYR A 327HIS A 449TYR A 473 | MC5 A 1 (-4.4A)NoneMC5 A 1 (-2.6A)MC5 A 1 (-3.8A)NoneMC5 A 1 (-3.9A)MC5 A 1 (-4.9A) | 1.17A | 3dzyD-3b0qA:22.5 | 3dzyD-3b0qA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3DZY_D_BRLD478_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 11 / 12 | PHE A 282CYH A 285SER A 289HIS A 323TYR A 327LEU A 330VAL A 339LEU A 353MET A 364HIS A 449TYR A 473 | MC5 A 1 (-4.4A)MC5 A 1 (-3.6A)MC5 A 1 (-2.6A)MC5 A 1 (-3.8A)NoneMC5 A 1 (-4.4A)MC5 A 1 (-4.6A)MC5 A 1 (-4.7A)MC5 A 1 (-3.7A)MC5 A 1 (-3.9A)MC5 A 1 (-4.9A) | 0.62A | 3dzyD-3b0qA:22.5 | 3dzyD-3b0qA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3DZY_D_BRLD478_2 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 4 / 4 | ILE A 281GLN A 286ILE A 341LEU A 453 | MC5 A 1 ( 4.8A)NoneMC5 A 1 (-4.5A)MC5 A 1 (-4.2A) | 0.67A | 3dzyD-3b0qA:22.5 | 3dzyD-3b0qA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3G8I_A_RO7A1_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 5 / 12 | CYH A 285SER A 289MET A 364HIS A 449TYR A 473 | MC5 A 1 (-3.6A)MC5 A 1 (-2.6A)MC5 A 1 (-3.7A)MC5 A 1 (-3.9A)MC5 A 1 (-4.9A) | 0.92A | 3g8iA-3b0qA:36.7 | 3g8iA-3b0qA:61.85 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3G8I_A_RO7A1_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 5 / 12 | SER A 289MET A 334MET A 364HIS A 449TYR A 473 | MC5 A 1 (-2.6A)NoneMC5 A 1 (-3.7A)MC5 A 1 (-3.9A)MC5 A 1 (-4.9A) | 1.27A | 3g8iA-3b0qA:36.7 | 3g8iA-3b0qA:61.85 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3G8I_A_RO7A1_2 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 5 / 7 | GLN A 286LEU A 330LEU A 353LYS A 367LEU A 469 | NoneMC5 A 1 (-4.4A)MC5 A 1 (-4.7A)NoneMC5 A 1 (-4.1A) | 0.72A | 3g8iA-3b0qA:36.7 | 3g8iA-3b0qA:61.85 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3G8I_A_RO7A1_2 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 5 / 7 | LEU A 255GLN A 286LEU A 330LEU A 353LYS A 367 | NoneNoneMC5 A 1 (-4.4A)MC5 A 1 (-4.7A)None | 0.92A | 3g8iA-3b0qA:36.7 | 3g8iA-3b0qA:61.85 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3G9E_A_RO7A1_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 12 / 12 | GLY A 284CYH A 285SER A 289HIS A 323TYR A 327LEU A 330VAL A 339ILE A 341LYS A 367HIS A 449LEU A 469TYR A 473 | MC5 A 1 ( 4.5A)MC5 A 1 (-3.6A)MC5 A 1 (-2.6A)MC5 A 1 (-3.8A)NoneMC5 A 1 (-4.4A)MC5 A 1 (-4.6A)MC5 A 1 (-4.5A)NoneMC5 A 1 (-3.9A)MC5 A 1 (-4.1A)MC5 A 1 (-4.9A) | 0.54A | 3g9eA-3b0qA:40.3 | 3g9eA-3b0qA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3GWX_A_EPAA1_1 (PROTEIN (PEROXISOMEPROLIFERATORACTIVATED RECEPTOR(PPAR-DELTA))) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 6 / 10 | PHE A 282GLN A 286ILE A 326MET A 329LEU A 353LYS A 367 | MC5 A 1 (-4.4A)NoneMC5 A 1 ( 4.9A)NoneMC5 A 1 (-4.7A)None | 0.65A | 3gwxA-3b0qA:36.2 | 3gwxA-3b0qA:61.68 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3GWX_A_EPAA1_2 (PROTEIN (PEROXISOMEPROLIFERATORACTIVATED RECEPTOR(PPAR-DELTA))) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 5 / 12 | CYH A 285HIS A 323HIS A 449LEU A 469TYR A 473 | MC5 A 1 (-3.6A)MC5 A 1 (-3.8A)MC5 A 1 (-3.9A)MC5 A 1 (-4.1A)MC5 A 1 (-4.9A) | 0.67A | 3gwxA-3b0qA:36.2 | 3gwxA-3b0qA:61.68 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3GWX_A_EPAA1_2 (PROTEIN (PEROXISOMEPROLIFERATORACTIVATED RECEPTOR(PPAR-DELTA))) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 5 / 12 | CYH A 285HIS A 323LEU A 330HIS A 449TYR A 473 | MC5 A 1 (-3.6A)MC5 A 1 (-3.8A)MC5 A 1 (-4.4A)MC5 A 1 (-3.9A)MC5 A 1 (-4.9A) | 0.87A | 3gwxA-3b0qA:36.2 | 3gwxA-3b0qA:61.68 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3GWX_B_EPAB3_1 (PROTEIN (PEROXISOMEPROLIFERATORACTIVATED RECEPTOR(PPAR-DELTA))) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 8 / 12 | CYH A 285GLU A 295HIS A 323LEU A 330LYS A 367HIS A 449LEU A 469TYR A 473 | MC5 A 1 (-3.6A)NoneMC5 A 1 (-3.8A)MC5 A 1 (-4.4A)NoneMC5 A 1 (-3.9A)MC5 A 1 (-4.1A)MC5 A 1 (-4.9A) | 0.78A | 3gwxB-3b0qA:36.6 | 3gwxB-3b0qA:61.68 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3GWX_B_EPAB3_1 (PROTEIN (PEROXISOMEPROLIFERATORACTIVATED RECEPTOR(PPAR-DELTA))) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 6 / 12 | GLU A 291HIS A 323LEU A 330LYS A 367HIS A 449TYR A 473 | NoneMC5 A 1 (-3.8A)MC5 A 1 (-4.4A)NoneMC5 A 1 (-3.9A)MC5 A 1 (-4.9A) | 1.26A | 3gwxB-3b0qA:36.6 | 3gwxB-3b0qA:61.68 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3GWX_B_EPAB3_2 (PROTEIN (PEROXISOMEPROLIFERATORACTIVATED RECEPTOR(PPAR-DELTA))) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 6 / 12 | LEU A 255PHE A 282GLN A 286ILE A 326MET A 329LEU A 353 | NoneMC5 A 1 (-4.4A)NoneMC5 A 1 ( 4.9A)NoneMC5 A 1 (-4.7A) | 0.69A | 3gwxB-3b0qA:36.6 | 3gwxB-3b0qA:61.68 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3QT0_A_486A4_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 10 / 12 | ARG A 288ALA A 292TYR A 327LEU A 330ILE A 341MET A 348PHE A 363MET A 364LYS A 367HIS A 449 | NoneNoneNoneMC5 A 1 (-4.4A)MC5 A 1 (-4.5A)MC5 A 1 ( 4.0A)NoneMC5 A 1 (-3.7A)NoneMC5 A 1 (-3.9A) | 0.72A | 3qt0A-3b0qA:38.5 | 3qt0A-3b0qA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3QT0_A_486A4_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 10 / 12 | CYH A 285ARG A 288ALA A 292TYR A 327LEU A 330ILE A 341MET A 348PHE A 363LYS A 367HIS A 449 | MC5 A 1 (-3.6A)NoneNoneNoneMC5 A 1 (-4.4A)MC5 A 1 (-4.5A)MC5 A 1 ( 4.0A)NoneNoneMC5 A 1 (-3.9A) | 0.61A | 3qt0A-3b0qA:38.5 | 3qt0A-3b0qA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3QT0_A_486A4_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 10 / 12 | CYH A 285ARG A 288SER A 289ALA A 292LEU A 330ILE A 341MET A 348PHE A 363LYS A 367HIS A 449 | MC5 A 1 (-3.6A)NoneMC5 A 1 (-2.6A)NoneMC5 A 1 (-4.4A)MC5 A 1 (-4.5A)MC5 A 1 ( 4.0A)NoneNoneMC5 A 1 (-3.9A) | 0.77A | 3qt0A-3b0qA:38.5 | 3qt0A-3b0qA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3SP6_A_IL2A901_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 5 / 12 | CYH A 285SER A 289MET A 364HIS A 449TYR A 473 | MC5 A 1 (-3.6A)MC5 A 1 (-2.6A)MC5 A 1 (-3.7A)MC5 A 1 (-3.9A)MC5 A 1 (-4.9A) | 0.75A | 3sp6A-3b0qA:38.0 | 3sp6A-3b0qA:59.30 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3SP9_A_IL2A901_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR DELTA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 5 / 12 | PHE A 282CYH A 285HIS A 323ILE A 326TYR A 473 | MC5 A 1 (-4.4A)MC5 A 1 (-3.6A)MC5 A 1 (-3.8A)MC5 A 1 ( 4.9A)MC5 A 1 (-4.9A) | 0.86A | 3sp9A-3b0qA:36.4 | 3sp9A-3b0qA:61.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3SP9_A_IL2A901_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR DELTA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 5 / 12 | PHE A 282CYH A 285ILE A 326HIS A 449TYR A 473 | MC5 A 1 (-4.4A)MC5 A 1 (-3.6A)MC5 A 1 ( 4.9A)MC5 A 1 (-3.9A)MC5 A 1 (-4.9A) | 1.19A | 3sp9A-3b0qA:36.4 | 3sp9A-3b0qA:61.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3SP9_B_IL2B901_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR DELTA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 5 / 12 | PHE A 282CYH A 285HIS A 323ILE A 326TYR A 473 | MC5 A 1 (-4.4A)MC5 A 1 (-3.6A)MC5 A 1 (-3.8A)MC5 A 1 ( 4.9A)MC5 A 1 (-4.9A) | 0.88A | 3sp9B-3b0qA:36.2 | 3sp9B-3b0qA:61.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3SP9_B_IL2B901_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR DELTA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 5 / 12 | PHE A 282CYH A 285ILE A 326HIS A 449TYR A 473 | MC5 A 1 (-4.4A)MC5 A 1 (-3.6A)MC5 A 1 ( 4.9A)MC5 A 1 (-3.9A)MC5 A 1 (-4.9A) | 1.14A | 3sp9B-3b0qA:36.2 | 3sp9B-3b0qA:61.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3VN2_A_TLSA501_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 9 / 12 | CYH A 285SER A 289ILE A 326TYR A 327LEU A 330LEU A 353MET A 364HIS A 449TYR A 473 | MC5 A 1 (-3.6A)MC5 A 1 (-2.6A)MC5 A 1 ( 4.9A)NoneMC5 A 1 (-4.4A)MC5 A 1 (-4.7A)MC5 A 1 (-3.7A)MC5 A 1 (-3.9A)MC5 A 1 (-4.9A) | 0.72A | 3vn2A-3b0qA:40.5 | 3vn2A-3b0qA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3VN2_A_TLSA501_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 5 / 12 | PHE A 282CYH A 285SER A 289ILE A 326TYR A 473 | MC5 A 1 (-4.4A)MC5 A 1 (-3.6A)MC5 A 1 (-2.6A)MC5 A 1 ( 4.9A)MC5 A 1 (-4.9A) | 0.85A | 3vn2A-3b0qA:40.5 | 3vn2A-3b0qA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3VN2_A_TLSA501_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 5 / 12 | SER A 289ILE A 326LEU A 330PHE A 282TYR A 473 | MC5 A 1 (-2.6A)MC5 A 1 ( 4.9A)MC5 A 1 (-4.4A)MC5 A 1 (-4.4A)MC5 A 1 (-4.9A) | 1.20A | 3vn2A-3b0qA:40.5 | 3vn2A-3b0qA:100.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4A97_C_ZPCC1318_1 (CYS-LOOPLIGAND-GATED IONCHANNEL) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 5 / 12 | PHE A 368VAL A 339ILE A 341GLU A 365ILE A 445 | NoneMC5 A 1 (-4.6A)MC5 A 1 (-4.5A)NoneNone | 1.27A | 4a97B-3b0qA:undetectable4a97C-3b0qA:undetectable | 4a97B-3b0qA:20.004a97C-3b0qA:20.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4EMA_A_BRLA601_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 12 / 12 | GLY A 284CYH A 285SER A 289HIS A 323TYR A 327LEU A 330MET A 348MET A 364HIS A 449LEU A 453LEU A 469TYR A 473 | MC5 A 1 ( 4.5A)MC5 A 1 (-3.6A)MC5 A 1 (-2.6A)MC5 A 1 (-3.8A)NoneMC5 A 1 (-4.4A)MC5 A 1 ( 4.0A)MC5 A 1 (-3.7A)MC5 A 1 (-3.9A)MC5 A 1 (-4.2A)MC5 A 1 (-4.1A)MC5 A 1 (-4.9A) | 0.52A | 4emaA-3b0qA:40.9 | 4emaA-3b0qA:98.54 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4EMA_A_BRLA601_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 5 / 12 | GLY A 284CYH A 285TYR A 327LEU A 330LEU A 452 | MC5 A 1 ( 4.5A)MC5 A 1 (-3.6A)NoneMC5 A 1 (-4.4A)None | 1.31A | 4emaA-3b0qA:40.9 | 4emaA-3b0qA:98.54 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4EMA_A_BRLA601_2 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 3 / 3 | PHE A 282VAL A 339ILE A 341 | MC5 A 1 (-4.4A)MC5 A 1 (-4.6A)MC5 A 1 (-4.5A) | 0.38A | 4emaA-3b0qA:40.9 | 4emaA-3b0qA:98.54 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4O8F_A_BRLA501_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 8 / 12 | PHE A 282ARG A 288SER A 289TYR A 327MET A 364HIS A 449LEU A 469TYR A 473 | MC5 A 1 (-4.4A)NoneMC5 A 1 (-2.6A)NoneMC5 A 1 (-3.7A)MC5 A 1 (-3.9A)MC5 A 1 (-4.1A)MC5 A 1 (-4.9A) | 1.31A | 4o8fA-3b0qA:38.8 | 4o8fA-3b0qA:99.64 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4O8F_A_BRLA501_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 6 / 12 | PHE A 282CYH A 285MET A 348MET A 364HIS A 449LEU A 465 | MC5 A 1 (-4.4A)MC5 A 1 (-3.6A)MC5 A 1 ( 4.0A)MC5 A 1 (-3.7A)MC5 A 1 (-3.9A)None | 1.41A | 4o8fA-3b0qA:38.8 | 4o8fA-3b0qA:99.64 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4O8F_A_BRLA501_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 11 / 12 | PHE A 282CYH A 285SER A 289HIS A 323TYR A 327VAL A 339MET A 348MET A 364HIS A 449LEU A 469TYR A 473 | MC5 A 1 (-4.4A)MC5 A 1 (-3.6A)MC5 A 1 (-2.6A)MC5 A 1 (-3.8A)NoneMC5 A 1 (-4.6A)MC5 A 1 ( 4.0A)MC5 A 1 (-3.7A)MC5 A 1 (-3.9A)MC5 A 1 (-4.1A)MC5 A 1 (-4.9A) | 0.37A | 4o8fA-3b0qA:38.8 | 4o8fA-3b0qA:99.64 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4O8F_A_BRLA501_2 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 5 / 5 | GLY A 284LEU A 330ILE A 341LEU A 353LEU A 453 | MC5 A 1 ( 4.5A)MC5 A 1 (-4.4A)MC5 A 1 (-4.5A)MC5 A 1 (-4.7A)MC5 A 1 (-4.2A) | 0.51A | 4o8fA-3b0qA:38.8 | 4o8fA-3b0qA:99.64 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4O8F_A_BRLA501_2 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 4 / 5 | GLY A 284LEU A 353ILE A 341LEU A 255 | MC5 A 1 ( 4.5A)MC5 A 1 (-4.7A)MC5 A 1 (-4.5A)None | 0.84A | 4o8fA-3b0qA:38.8 | 4o8fA-3b0qA:99.64 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4O8F_B_BRLB501_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 11 / 12 | CYH A 285SER A 289HIS A 323LEU A 330VAL A 339MET A 348MET A 364HIS A 449LEU A 453LEU A 469TYR A 473 | MC5 A 1 (-3.6A)MC5 A 1 (-2.6A)MC5 A 1 (-3.8A)MC5 A 1 (-4.4A)MC5 A 1 (-4.6A)MC5 A 1 ( 4.0A)MC5 A 1 (-3.7A)MC5 A 1 (-3.9A)MC5 A 1 (-4.2A)MC5 A 1 (-4.1A)MC5 A 1 (-4.9A) | 0.61A | 4o8fB-3b0qA:21.7 | 4o8fB-3b0qA:99.64 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4O8F_B_BRLB501_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 7 / 12 | CYH A 285SER A 289LEU A 330VAL A 339PHE A 363MET A 364HIS A 449 | MC5 A 1 (-3.6A)MC5 A 1 (-2.6A)MC5 A 1 (-4.4A)MC5 A 1 (-4.6A)NoneMC5 A 1 (-3.7A)MC5 A 1 (-3.9A) | 0.73A | 4o8fB-3b0qA:21.7 | 4o8fB-3b0qA:99.64 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4O8F_B_BRLB501_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 5 / 12 | SER A 289HIS A 323PHE A 282HIS A 449TYR A 473 | MC5 A 1 (-2.6A)MC5 A 1 (-3.8A)MC5 A 1 (-4.4A)MC5 A 1 (-3.9A)MC5 A 1 (-4.9A) | 1.47A | 4o8fB-3b0qA:21.7 | 4o8fB-3b0qA:99.64 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4O8F_B_BRLB501_2 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 5 / 6 | ILE A 281GLY A 284ILE A 326ILE A 341LEU A 353 | MC5 A 1 ( 4.8A)MC5 A 1 ( 4.5A)MC5 A 1 ( 4.9A)MC5 A 1 (-4.5A)MC5 A 1 (-4.7A) | 0.59A | 4o8fB-3b0qA:37.8 | 4o8fB-3b0qA:99.64 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4O8F_B_BRLB501_2 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 5 / 6 | ILE A 281PHE A 282GLY A 284ILE A 341LEU A 353 | MC5 A 1 ( 4.8A)MC5 A 1 (-4.4A)MC5 A 1 ( 4.5A)MC5 A 1 (-4.5A)MC5 A 1 (-4.7A) | 0.68A | 4o8fB-3b0qA:37.8 | 4o8fB-3b0qA:99.64 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OJ4_A_DIFA501_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 6 / 8 | CYH A 285LEU A 330LEU A 333VAL A 339ILE A 341MET A 364 | MC5 A 1 (-3.6A)MC5 A 1 (-4.4A)NoneMC5 A 1 (-4.6A)MC5 A 1 (-4.5A)MC5 A 1 (-3.7A) | 0.67A | 4oj4A-3b0qA:37.4 | 4oj4A-3b0qA:98.19 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OJ4_A_DIFA501_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 5 / 8 | SER A 289LEU A 330LEU A 333VAL A 339MET A 364 | MC5 A 1 (-2.6A)MC5 A 1 (-4.4A)NoneMC5 A 1 (-4.6A)MC5 A 1 (-3.7A) | 0.65A | 4oj4A-3b0qA:37.4 | 4oj4A-3b0qA:98.19 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4XLD_A_BRLA502_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 11 / 12 | PHE A 282GLY A 284CYH A 285SER A 289HIS A 323TYR A 327LEU A 330MET A 364HIS A 449LEU A 469TYR A 473 | MC5 A 1 (-4.4A)MC5 A 1 ( 4.5A)MC5 A 1 (-3.6A)MC5 A 1 (-2.6A)MC5 A 1 (-3.8A)NoneMC5 A 1 (-4.4A)MC5 A 1 (-3.7A)MC5 A 1 (-3.9A)MC5 A 1 (-4.1A)MC5 A 1 (-4.9A) | 0.48A | 4xldA-3b0qA:39.8 | 4xldA-3b0qA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4XLD_A_BRLA502_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 7 / 12 | PHE A 282GLY A 284CYH A 285SER A 289LEU A 330PHE A 363MET A 364 | MC5 A 1 (-4.4A)MC5 A 1 ( 4.5A)MC5 A 1 (-3.6A)MC5 A 1 (-2.6A)MC5 A 1 (-4.4A)NoneMC5 A 1 (-3.7A) | 0.87A | 4xldA-3b0qA:39.8 | 4xldA-3b0qA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4XLD_A_BRLA502_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 5 / 12 | SER A 289HIS A 323PHE A 282HIS A 449TYR A 473 | MC5 A 1 (-2.6A)MC5 A 1 (-3.8A)MC5 A 1 (-4.4A)MC5 A 1 (-3.9A)MC5 A 1 (-4.9A) | 1.12A | 4xldA-3b0qA:39.8 | 4xldA-3b0qA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4XTA_A_DIFA501_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 6 / 9 | ALA A 292GLU A 295MET A 329LEU A 330LEU A 333ILE A 341 | NoneNoneNoneMC5 A 1 (-4.4A)NoneMC5 A 1 (-4.5A) | 0.43A | 4xtaA-3b0qA:37.9 | 4xtaA-3b0qA:98.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4XTA_A_DIFA501_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 6 / 9 | CYH A 285GLU A 295MET A 329LEU A 330LEU A 333ILE A 341 | MC5 A 1 (-3.6A)NoneNoneMC5 A 1 (-4.4A)NoneMC5 A 1 (-4.5A) | 0.71A | 4xtaA-3b0qA:37.9 | 4xtaA-3b0qA:98.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4XTA_A_DIFA501_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 6 / 9 | SER A 289ALA A 292GLU A 295MET A 329LEU A 330LEU A 333 | MC5 A 1 (-2.6A)NoneNoneNoneMC5 A 1 (-4.4A)None | 0.57A | 4xtaA-3b0qA:37.9 | 4xtaA-3b0qA:98.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4XTA_B_DIFB501_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 6 / 8 | CYH A 285ARG A 288LEU A 330LEU A 333ILE A 341MET A 364 | MC5 A 1 (-3.6A)NoneMC5 A 1 (-4.4A)NoneMC5 A 1 (-4.5A)MC5 A 1 (-3.7A) | 0.83A | 4xtaB-3b0qA:36.3 | 4xtaB-3b0qA:98.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4XTA_B_DIFB501_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 6 / 8 | ILE A 281ARG A 288LEU A 330LEU A 333ILE A 341MET A 364 | MC5 A 1 ( 4.8A)NoneMC5 A 1 (-4.4A)NoneMC5 A 1 (-4.5A)MC5 A 1 (-3.7A) | 0.51A | 4xtaB-3b0qA:36.3 | 4xtaB-3b0qA:98.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4XTA_B_DIFB501_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 6 / 8 | ILE A 281ARG A 288SER A 289LEU A 330LEU A 333MET A 364 | MC5 A 1 ( 4.8A)NoneMC5 A 1 (-2.6A)MC5 A 1 (-4.4A)NoneMC5 A 1 (-3.7A) | 0.57A | 4xtaB-3b0qA:36.3 | 4xtaB-3b0qA:98.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4XUM_A_IMNA501_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 10 / 12 | CYH A 285SER A 289HIS A 323ILE A 326MET A 364HIS A 449LEU A 453LEU A 465LEU A 469TYR A 473 | MC5 A 1 (-3.6A)MC5 A 1 (-2.6A)MC5 A 1 (-3.8A)MC5 A 1 ( 4.9A)MC5 A 1 (-3.7A)MC5 A 1 (-3.9A)MC5 A 1 (-4.2A)NoneMC5 A 1 (-4.1A)MC5 A 1 (-4.9A) | 0.70A | 4xumA-3b0qA:41.1 | 4xumA-3b0qA:98.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4XUM_A_IMNA501_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 5 / 12 | HIS A 323ILE A 326PHE A 282LEU A 453TYR A 473 | MC5 A 1 (-3.8A)MC5 A 1 ( 4.9A)MC5 A 1 (-4.4A)MC5 A 1 (-4.2A)MC5 A 1 (-4.9A) | 1.09A | 4xumA-3b0qA:41.1 | 4xumA-3b0qA:98.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4XUM_A_IMNA501_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 5 / 12 | PHE A 282CYH A 285SER A 289HIS A 323LEU A 469 | MC5 A 1 (-4.4A)MC5 A 1 (-3.6A)MC5 A 1 (-2.6A)MC5 A 1 (-3.8A)MC5 A 1 (-4.1A) | 0.94A | 4xumA-3b0qA:41.1 | 4xumA-3b0qA:98.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4XUM_A_IMNA502_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 7 / 7 | GLU A 259ILE A 281CYH A 285ARG A 288LEU A 330ILE A 341MET A 348 | NoneMC5 A 1 ( 4.8A)MC5 A 1 (-3.6A)NoneMC5 A 1 (-4.4A)MC5 A 1 (-4.5A)MC5 A 1 ( 4.0A) | 0.54A | 4xumA-3b0qA:41.1 | 4xumA-3b0qA:98.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4XUM_B_IMNB501_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 10 / 11 | GLY A 284ARG A 288SER A 289ALA A 292ILE A 326MET A 329LEU A 330LEU A 333ILE A 341MET A 348 | MC5 A 1 ( 4.5A)NoneMC5 A 1 (-2.6A)NoneMC5 A 1 ( 4.9A)NoneMC5 A 1 (-4.4A)NoneMC5 A 1 (-4.5A)MC5 A 1 ( 4.0A) | 0.55A | 4xumB-3b0qA:36.3 | 4xumB-3b0qA:98.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4XUM_B_IMNB501_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 7 / 11 | GLY A 284CYH A 285ARG A 288ALA A 292MET A 329LEU A 330LEU A 333 | MC5 A 1 ( 4.5A)MC5 A 1 (-3.6A)NoneNoneNoneMC5 A 1 (-4.4A)None | 0.86A | 4xumB-3b0qA:36.3 | 4xumB-3b0qA:98.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5G48_B_1FLB1375_1 (DNA POLYMERASE IIISUBUNIT BETA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 5 / 9 | LEU A 353THR A 349ILE A 341PRO A 246LEU A 340 | MC5 A 1 (-4.7A)NoneMC5 A 1 (-4.5A)NoneNone | 1.31A | 5g48B-3b0qA:undetectable | 5g48B-3b0qA:24.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JI0_D_BRLD501_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 12 / 12 | PHE A 282GLY A 284CYH A 285GLN A 286SER A 289HIS A 323TYR A 327LEU A 330MET A 364HIS A 449LEU A 453TYR A 473 | MC5 A 1 (-4.4A)MC5 A 1 ( 4.5A)MC5 A 1 (-3.6A)NoneMC5 A 1 (-2.6A)MC5 A 1 (-3.8A)NoneMC5 A 1 (-4.4A)MC5 A 1 (-3.7A)MC5 A 1 (-3.9A)MC5 A 1 (-4.2A)MC5 A 1 (-4.9A) | 0.58A | 5ji0D-3b0qA:40.5 | 5ji0D-3b0qA:98.91 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5Y2O_A_8N6A501_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 6 / 12 | PHE A 282CYH A 285LEU A 330PHE A 363MET A 364LEU A 453 | MC5 A 1 (-4.4A)MC5 A 1 (-3.6A)MC5 A 1 (-4.4A)NoneMC5 A 1 (-3.7A)MC5 A 1 (-4.2A) | 0.90A | 5y2oA-3b0qA:40.9 | 5y2oA-3b0qA:73.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5Y2O_A_8N6A501_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 5 / 12 | PHE A 282CYH A 285MET A 364HIS A 449LEU A 465 | MC5 A 1 (-4.4A)MC5 A 1 (-3.6A)MC5 A 1 (-3.7A)MC5 A 1 (-3.9A)None | 1.50A | 5y2oA-3b0qA:40.9 | 5y2oA-3b0qA:73.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5Y2O_A_8N6A501_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 11 / 12 | PHE A 282CYH A 285SER A 289HIS A 323TYR A 327LEU A 330MET A 364HIS A 449LEU A 453LEU A 469TYR A 473 | MC5 A 1 (-4.4A)MC5 A 1 (-3.6A)MC5 A 1 (-2.6A)MC5 A 1 (-3.8A)NoneMC5 A 1 (-4.4A)MC5 A 1 (-3.7A)MC5 A 1 (-3.9A)MC5 A 1 (-4.2A)MC5 A 1 (-4.1A)MC5 A 1 (-4.9A) | 0.57A | 5y2oA-3b0qA:40.9 | 5y2oA-3b0qA:73.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5Y2T_A_8LXA501_0 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 6 / 12 | LEU A 255CYH A 285LEU A 330ILE A 341MET A 348LEU A 465 | NoneMC5 A 1 (-3.6A)MC5 A 1 (-4.4A)MC5 A 1 (-4.5A)MC5 A 1 ( 4.0A)None | 1.23A | 5y2tA-3b0qA:40.2 | 5y2tA-3b0qA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5Y2T_A_8LXA501_0 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 12 / 12 | LEU A 255PHE A 282GLY A 284CYH A 285GLN A 286TYR A 327LEU A 330ILE A 341MET A 348MET A 364HIS A 449LEU A 453 | NoneMC5 A 1 (-4.4A)MC5 A 1 ( 4.5A)MC5 A 1 (-3.6A)NoneNoneMC5 A 1 (-4.4A)MC5 A 1 (-4.5A)MC5 A 1 ( 4.0A)MC5 A 1 (-3.7A)MC5 A 1 (-3.9A)MC5 A 1 (-4.2A) | 0.60A | 5y2tA-3b0qA:40.2 | 5y2tA-3b0qA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5Y2T_A_8LXA501_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 3 / 3 | SER A 289HIS A 323TYR A 473 | MC5 A 1 (-2.6A)MC5 A 1 (-3.8A)MC5 A 1 (-4.9A) | 0.34A | 5y2tA-3b0qA:40.2 | 5y2tA-3b0qA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5Y2T_B_8LXB501_0 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 11 / 12 | LEU A 255ARG A 280ILE A 281CYH A 285GLN A 286ILE A 326TYR A 327LEU A 330ILE A 341MET A 348HIS A 449 | NoneNoneMC5 A 1 ( 4.8A)MC5 A 1 (-3.6A)NoneMC5 A 1 ( 4.9A)NoneMC5 A 1 (-4.4A)MC5 A 1 (-4.5A)MC5 A 1 ( 4.0A)MC5 A 1 (-3.9A) | 0.61A | 5y2tB-3b0qA:36.8 | 5y2tB-3b0qA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5Y2T_B_8LXB501_0 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 5 / 12 | LEU A 255ILE A 281GLN A 283ILE A 341MET A 348 | NoneMC5 A 1 ( 4.8A)NoneMC5 A 1 (-4.5A)MC5 A 1 ( 4.0A) | 1.08A | 5y2tB-3b0qA:36.8 | 5y2tB-3b0qA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5Y2T_B_8LXB501_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 5 / 8 | GLU A 259PHE A 282PHE A 363MET A 364LEU A 453 | NoneMC5 A 1 (-4.4A)NoneMC5 A 1 (-3.7A)MC5 A 1 (-4.2A) | 1.00A | 5y2tB-3b0qA:36.8 | 5y2tB-3b0qA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5Y2T_B_8LXB501_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 5 / 8 | GLU A 259PHE A 282SER A 289HIS A 323MET A 364 | NoneMC5 A 1 (-4.4A)MC5 A 1 (-2.6A)MC5 A 1 (-3.8A)MC5 A 1 (-3.7A) | 0.79A | 5y2tB-3b0qA:36.8 | 5y2tB-3b0qA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5Y2T_B_8LXB501_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 5 / 8 | GLU A 259PHE A 282SER A 289MET A 364LEU A 453 | NoneMC5 A 1 (-4.4A)MC5 A 1 (-2.6A)MC5 A 1 (-3.7A)MC5 A 1 (-4.2A) | 0.89A | 5y2tB-3b0qA:36.8 | 5y2tB-3b0qA:undetectable | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5YCN_A_8LXA501_0 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 12 / 12 | LEU A 255ARG A 280ILE A 281GLY A 284TYR A 327LEU A 330VAL A 339ILE A 341MET A 348MET A 364LEU A 453LEU A 469 | NoneNoneMC5 A 1 ( 4.8A)MC5 A 1 ( 4.5A)NoneMC5 A 1 (-4.4A)MC5 A 1 (-4.6A)MC5 A 1 (-4.5A)MC5 A 1 ( 4.0A)MC5 A 1 (-3.7A)MC5 A 1 (-4.2A)MC5 A 1 (-4.1A) | 0.57A | 5ycnA-3b0qA:41.8 | 5ycnA-3b0qA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5YCN_A_8LXA501_0 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 5 / 12 | LEU A 255ILE A 281ILE A 341MET A 348LEU A 465 | NoneMC5 A 1 ( 4.8A)MC5 A 1 (-4.5A)MC5 A 1 ( 4.0A)None | 1.04A | 5ycnA-3b0qA:41.8 | 5ycnA-3b0qA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5YCN_A_8LXA501_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 6 / 6 | PHE A 282CYH A 285SER A 289HIS A 323HIS A 449TYR A 473 | MC5 A 1 (-4.4A)MC5 A 1 (-3.6A)MC5 A 1 (-2.6A)MC5 A 1 (-3.8A)MC5 A 1 (-3.9A)MC5 A 1 (-4.9A) | 0.39A | 5ycnA-3b0qA:41.8 | 5ycnA-3b0qA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5YCP_A_BRLA501_0 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 12 / 12 | PHE A 282CYH A 285SER A 289HIS A 323TYR A 327LEU A 330ILE A 341MET A 364HIS A 449LEU A 453LEU A 469TYR A 473 | MC5 A 1 (-4.4A)MC5 A 1 (-3.6A)MC5 A 1 (-2.6A)MC5 A 1 (-3.8A)NoneMC5 A 1 (-4.4A)MC5 A 1 (-4.5A)MC5 A 1 (-3.7A)MC5 A 1 (-3.9A)MC5 A 1 (-4.2A)MC5 A 1 (-4.1A)MC5 A 1 (-4.9A) | 0.46A | 5ycpA-3b0qA:41.9 | 5ycpA-3b0qA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5YCP_A_BRLA501_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 3 / 3 | GLY A 284VAL A 339MET A 348 | MC5 A 1 ( 4.5A)MC5 A 1 (-4.6A)MC5 A 1 ( 4.0A) | 0.21A | 5ycpA-3b0qA:41.9 | 5ycpA-3b0qA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6MD4_A_BRLA501_0 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
3b0q | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA (Homosapiens) | 12 / 12 | PHE A 282GLY A 284CYH A 285GLN A 286SER A 289HIS A 323TYR A 327LEU A 330ILE A 341MET A 364HIS A 449TYR A 473 | MC5 A 1 (-4.4A)MC5 A 1 ( 4.5A)MC5 A 1 (-3.6A)NoneMC5 A 1 (-2.6A)MC5 A 1 (-3.8A)NoneMC5 A 1 (-4.4A)MC5 A 1 (-4.5A)MC5 A 1 (-3.7A)MC5 A 1 (-3.9A)MC5 A 1 (-4.9A) | 0.58A | 6md4A-3b0qA:40.8 | 6md4A-3b0qA:100.00 |